PEOPLE - Changes at Quest Diagnostics:
This article was originally published in Clinica
Robert Hagemann has been promoted to vice-president and chief financial officer of Quest Diagnostics, a US provider of diagnostic testing services. He succeeds Robert Carothers who is to retire. In addition, William Buehler of Xerox, a publishing systems company, has been elected to the board of directors.
You may also be interested in...
Immuno-oncology has produced some exciting successes, but the field has become intensely crowded. Enormous resources are being poured into duplicative work and shaky hypotheses—overshadowing other pursuits in cancer research while producing limited results. It is time to re-evaluate how the sector should be pursuing innovation in cancer and how it can be smarter in its use of resources—financial investment, talent, bandwidth, patients and data.
The Pink Sheet’s list of EU centralized approvals of new active substances has been updated with seven new products including Roche's Polivy for treating diffuse large B-cell lymphoma. The list, which contains information dating back to January 2018, includes brand name, generic name, company, therapeutic indication, date of marketing authorization and product type (eg, medicine, vaccine, biologic).